Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes

Free Radical Biology and Medicine

Volumn 43, Issue 6, 2007, Pages 987-992

  Metzger, Ingrid F ^a   Sertório, Jonas T C ^a   Tanus Santos, Jose E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Endothelial nitric oxide synthase; Free radicals; Genotypes; Haplotypes; Nitric oxide; Nitrite; Polymorphisms

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME IMMUNOASSAY; HAPLOTYPE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROMOTER REGION;

ADOLESCENT; ADULT; CYCLIC GMP; FEMALE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; NITRITES; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 34547653833     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.06.012     Document Type: Article

References (45)

1. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., and Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA 84 (1987) 9265-9269
2. Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43 (1991) 109-142
3. Hingorani A.D. Polymorphisms in endothelial nitric oxide synthase and atherogenesis: John French Lecture 2000. Atherosclerosis 154 (2001) 521-527
4. Wattanapitayakul S.K., Mihm M.J., Young A.P., and Bauer J.A. Therapeutic implications of human endothelial nitric oxide synthase gene polymorphism. Trends Pharmacol. Sci. 22 (2001) 361-368
5. Wang X.L., and Wang J. Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol. Genet. Metab. 70 (2000) 241-251
6. Tanus-Santos J.E., Desai M., and Flockhart D.A. Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics 11 (2001) 719-725
7. Wang J., Dudley D., and Wang X.L. Haplotype-specific effects on endothelial NO synthase promoter efficiency: modifiable by cigarette smoking. Arterioscler. Thromb. Vasc. Biol. 22 (2002) e1-e4
8. Crawford D.C., and Nickerson D.A. Definition and clinical importance of haplotypes. Annu. Rev. Med. 56 (2005) 303-320
9. Johnson G.C., Esposito L., Barratt B.J., Smith A.N., Heward J., Di Genova G., Ueda H., Cordell H.J., Eaves I.A., Dudbridge F., Twells R.C., Payne F., Hughes W., Nutland S., Stevens H., Carr P., Tuomilehto-Wolf E., Tuomilehto J., Gough S.C., Clayton D.G., and Todd J.A. Haplotype tagging for the identification of common disease genes. Nat. Genet. 29 (2001) 233-237
10. Metzger I.F., Souza-Costa D.C., Marroni A.S., Nagassaki S., Desta Z., Flockhart D.A., and Tanus-Santos J.E. Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men. Pharmacogenet. Genomics 15 (2005) 565-570
11. Lauer T., Kleinbongard P., and Kelm M. Indexes of NO bioavailability in human blood. News Physiol. Sci. 17 (2002) 251-255
12. Lauer T., Preik M., Rassaf T., Strauer B.E., Deussen A., Feelisch M., and Kelm M. Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action. Proc. Natl. Acad. Sci. USA 98 (2001) 12814-12819
13. Metzger I.F., Sertorio J.T.C., and Tanus-Santos J.E. Relationship between systemic nitric oxide metabolites and cyclic GMP in healthy male volunteers. Acta Physiol. 188 (2006) 123-127
14. Kelm M., Preik-Steinhoff H., Preik M., and Strauer B.E. Serum nitrite sensitively reflects endothelial NO formation in human forearm vasculature: evidence for biochemical assessment of the endothelial l-arginine-NO pathway. Cardiovasc. Res. 41 (1999) 765-772
15. Kleinbongard P., Dejam A., Lauer T., Jax T., Kerber S., Gharini P., Balzer J., Zotz R.B., Scharf R.E., Willers R., Schechter A.N., Feelisch M., and Kelm M. Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humans. Free Radic. Biol. Med. 40 (2006) 295-302
16. Kleinbongard P., Dejam A., Lauer T., Rassaf T., Schindler A., Picker O., Scheeren T., Godecke A., Schrader J., Schulz R., Heusch G., Schaub G.A., Bryan N.S., Feelisch M., and Kelm M. Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radic. Biol. Med. 35 (2003) 790-796
17. Ellis G., Adatia I., Yazdanpanah M., and Makela S.K. Nitrite and nitrate analyses: a clinical biochemistry perspective. Clin. Biochem. 31 (1998) 195-220
18. Hassan A., Gormley K., O'Sullivan M., Knight J., Sham P., Vallance P., Bamford J., and Markus H. Endothelial nitric oxide gene haplotypes and risk of cerebral small-vessel disease. Stroke 35 (2004) 654-659
19. Kielstein J.T., Impraim B., Simmel S., Bode-Boger S.M., Tsikas D., Frolich J.C., Hoeper M.M., Haller H., and Fliser D. Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation 109 (2004) 172-177
20. Nagassaki S., Metzger I.F., Souza-Costa D.C., Marroni A.S., Uzuelli J.A., and Tanus-Santos J.E. eNOS genotype is without effect on circulating nitrite/nitrate level in healthy male population. Thromb. Res. 115 (2005) 375-379
21. Nagassaki S., Sertorio J.T.C., Metzger I.F., Bem A.F., Rocha J.B.T., and Tanus-Santos J.E. eNOS gene T-786C polymorphism modulates atorvastatin-induced increase in blood nitrite. Free Radic. Biol. Med. 41 (2006) 1044-1049
22. Tanus-Santos J.E., Desai M., Deak L.R., Pezzullo J.C., Abernethy D.R., Flockhart D.A., and Freedman J.E. Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiol. Pharmacogenetics 12 (2002) 407-413
23. Marroni A.S., Metzger I.F., Souza-Costa D.C., Nagassaki S., Sandrim V.C., Correa R.X., Rios-Santos F., and Tanus-Santos J.E. Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase (eNOS) genetic polymorphisms. Nitric Oxide 12 (2005) 177-182
24. Yang B.K., Vivas E.X., Reiter C.D., and Gladwin M.T. Methodologies for the sensitive and specific measurement of S-nitrosothiols, iron-nitrosyls, and nitrite in biological samples. Free Radic. Res. 37 (2003) 1-10
25. Dias-Junior C.A., and Tanus-Santos J.E. Hemodynamic effects of sildenafil interaction with a nitric oxide donor compound in a dog model of acute pulmonary embolism. Life Sci. 79 (2006) 469-474
26. Souza-Silva A.R., Dias-Junior C.A., Uzuelli J.A., Moreno Jr. H., Evora P.R., and Tanus-Santos J.E. Hemodynamic effects of combined sildenafil and l-arginine during acute pulmonary embolism-induced pulmonary hypertension. Eur. J. Pharmacol. 524 (2005) 126-131
27. Stephens M., Smith N.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68 (2001) 978-989
28. Rosselli M., Imthurn B., Keller P.J., Jackson E.K., and Dubey R.K. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol and norethisterone acetate: a two-year follow-up study. Hypertension 25 (1995) 848-853
29. Hibbs Jr. J.B., Westenfelder C., Taintor R., Vavrin Z., Kablitz C., Baranowski R.L., Ward J.H., Menlove R.L., McMurry M.P., Kushner J.P., et al. Evidence for cytokine-inducible nitric oxide synthesis from l-arginine in patients receiving interleukin-2 therapy. J. Clin. Invest. 89 (1992) 867-877
30. Wang X.L., Mahaney M.C., Sim A.S., Wang J., Blangero J., Almasy L., Badenhop R.B., and Wilcken D.E. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 3147-3153
31. Baylis C., and Vallance P. Measurement of nitrite and nitrate levels in plasma and urine-What does this measure tell us about the activity of the endogenous nitric oxide system?. Curr. Opin. Nephrol. Hypertens. 7 (1998) 59-62
32. Gladwin M.T., Raat H., Shiva S., Dezfulian C., Hogg N., Kim-Shapiro D.B., and Patel R.P. Nitrite as a vascular endocrine nitric oxide reservoir that contributes to hypoxic signaling, cytoprotection and vasodilation. Am. J. Physiol. Heart Circ. Physiol. 23 (2006) 23
33. Lundberg J.O. Nitric oxide metabolites and cardiovascular disease markers, mediators, or both?. J Am. Coll. Cardiol. 47 (2006) 580-581
34. Lundberg J.O., and Weitzberg E. NO generation from nitrite and its role in vascular control. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 915-922
35. Modin A., Bjorne H., Herulf M., Alving K., Weitzberg E., and Lundberg J.O. Nitrite-derived nitric oxide: a possible mediator of 'acidic-metabolic' vasodilation. Acta Physiol. Scand. 171 (2001) 9-16
36. Gladwin M.T., Crawford J.H., and Patel R.P. The biochemistry of nitric oxide, nitrite, and hemoglobin: role in blood flow regulation. Free Radic. Biol. Med. 36 (2004) 707-717
37. Pluta R.M., Dejam A., Grimes G., Gladwin M.T., and Oldfield E.H. Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage. JAMA 293 (2005) 1477-1484
38. Gladwin M.T. Hemoglobin as a nitrite reductase regulating red cell-dependent hypoxic vasodilation. Am. J. Respir. Cell Mol. Biol. 32 (2005) 363-366
39. Gladwin M.T. Nitrite as an intrinsic signaling molecule. Nat. Chem. Biol. 1 (2005) 245-246
40. Gladwin M.T., Schechter A.N., Kim-Shapiro D.B., Patel R.P., Hogg N., Shiva S., Cannon III R.O., Kelm M., Wink D.A., Espey M.G., Oldfield E.H., Pluta R.M., Freeman B.A., Lancaster Jr. J.R., Feelisch M., and Lundberg J.O. The emerging biology of the nitrite anion. Nat. Chem. Biol. 1 (2005) 308-314
41. Dias-Junior C.A., Gladwin M.T., and Tanus-Santos J.E. Low-dose intravenous nitrite improves hemodynamics in a canine model of acute pulmonary thromboembolism. Free Radic. Biol. Med. 41 (2006) 1764-1770
42. Duranski M.R., Greer J.J., Dejam A., Jaganmohan S., Hogg N., Langston W., Patel R.P., Yet S.F., Wang X., Kevil C.G., Gladwin M.T., and Lefer D.J. Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J. Clin. Invest. 115 (2005) 1232-1240
43. Webb A., Bond R., McLean P., Uppal R., Benjamin N., and Ahluwalia A. Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage. Proc. Natl. Acad. Sci. USA 101 (2004) 13683-13688
44. Kim H.P., Ryter S.W., and Choi A.M. CO as a cellular signaling molecule. Annu. Rev. Pharmacol. Toxicol. 46 (2006) 411-449
45. Hirata Y., Ishii M., Matsuoka H., Sugimoto T., Iizuka M., Uchida Y., Serizawa T., Sato H., Kohmoto O., Mochizuki T., et al. Plasma concentrations of alpha-human atrial natriuretic polypeptide and cyclic GMP in patients with heart disease. Am. Heart J. 113 (1987) 1463-1469